A Randomized Controlled Study of rhTPO and rhIL-11 for the Prophylactic Treatment of Chemotherapy-Induced Thrombocytopenia in Non-Small Cell Lung Cancer

Conclusion: Prophylactic administration of rhTPO helps to alleviate CIT in NSCLC as well as rhIL-11, but is safer to use and more convenient to administer.

Source: Journal of Cancer - December 14, 2018 Category: Cancer & Oncology Authors: Yunhua Xu, Xia Song, Fangmin Du, Qiong Zhao, Li Liu, Zhiyong Ma, Shun Lu Tags: Research Paper Source Type: research